← SynDRA
SECNIDAZOLE
SynDRA canonical compound SYN0016518 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | acetylcholinesterase inhibitor | microtubule inhibitor |
|---|
| Indication | protozoan infection |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- acetylcholinesterase inhibitor
- microtubule inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- FLT1
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MBNL1
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HRH2
- HRH1
- HMGCR
- HDAC6
- GMNN
- NPY1R
- NPY2R
- NR3C1
- SIGMAR1
- TBXAS1
- TARDBP
- TACR2
- TACR1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- SAMHD1
- OPRD1
- PTPRC
- PTGS2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Nitroimidazole Antimicrobial
- Anti-Infective Agents
- Antiparasitic Agents
- Antiprotozoal Agents
ATC classes
- P01A · AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
- COMBINATIONS OF ANTIBACTERIALS
Cross-references
Synonyms
- SOLOSEC
- Solosec
- solosec
- secnidazol
- seknidazol
- flagentyl
- Secnidazol
- Ornidazole metabolite m4
- Secnidal
- Secnidazole anhydrous
- NSC-759812
- PM-185184
- RP-14539
- SYM-1219
- Deprozol
- Flagentyl
- Sabima
- Secnol
- Secnidazolum
- Secnidazolum [INN-Latin]
- Secnidazol [INN-Spanish]
- PM 185184;Secnidazole (Flagentyl)
- EINECS 222-134-0
- MLS000559043
- NCGC00095158-01
- SMR000149359
- SYM 1219
- Secnidazole (Flagentyl)
- NSC 759812
- R3459K699K
- RP-14539;PM-185184
- CAS-3366-95-8
- SR-01000685111
- Sindose
- Secnil
- UNII-R3459K699K
- Secnidal (TN)
- Secnidazole-[d6]
Reported adverse events
- Abdominal pain
- Headache
- Nausea
- Vulvovaginal candidiasis
- Vulvovaginal pruritus
Look up SECNIDAZOLE in the interactive SynDRA portal →